Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Healthtrust
Julphar
Cerilliant
Deloitte
Cantor Fitzgerald
Fish and Richardson
AstraZeneca
Fuji
Dow

Generated: October 20, 2017

DrugPatentWatch Database Preview

POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9% Drug Profile

« Back to Dashboard

Which patents cover Potassium Chloride 0.224% In Sodium Chloride 0.9%, and what generic Potassium Chloride 0.224% In Sodium Chloride 0.9% alternatives are available?

Potassium Chloride 0.224% In Sodium Chloride 0.9% is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9% is potassium chloride; sodium chloride. There are two hundred and thirty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the potassium chloride; sodium chloride profile page.

Summary for Tradename: POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9%

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list3,040
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9% at DailyMed

Pharmacology for Tradename: POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare
POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9%
potassium chloride; sodium chloride
INJECTABLE;INJECTION017648-003Approved Prior to Jan 1, 1982RXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Julphar
Baxter
Chinese Patent Office
Cipla
Healthtrust
Fuji
Express Scripts
Covington
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot